In-cosmetics north america 11-12 October 2017
For the second time, bitop exhibited at in-cosmetics north america. We presented our all-natural, COSMOS and Natrue approved active ingredients Ectoin® and Glycoin® natural to the cosmetics industry. Trending topics were the blue-light protection and anti-pollution efficacy of our “wow-active” Ectoin® and the stimulating activity of our powerful cell-energizer Glycoin® natural.
Thank you New York! We are looking forward to come back in 2018.
bitop broadens its eye care portfolio with a new Ectoin® ophthalmology range
Witten, 04.10.2017 - Besides its well-established Ectoin®-containing eye drops, bitop currently broadens its ophthalmology product range with different additional Ectoin®- and Glycoin® natural containing products. These new product developments are designed to prevent or treat ophthalmological diseases such as dry eye syndrome, allergic conjunctivitis, eczema and blepharitis and will fulfill various customer preferences with regards to application forms.
The range extension contains four innovative Ectoin® formulations for the eye:
- Ectoin® Eye Serum for treatment of blepharitis
- Ectoin® Lid Wipes for treatment of dry, irritated and inflamed eye-lids
- Ectoin® Eye Spray for treatment of dry, tired, irritated and inflamed eyes
- Ectoin® Eye Gel for treatment of dry, tired, irritated and inflamed eyes
Ectoin® based products have already proven their efficacy and excellent tolerability for application in the eye in several clinical studies and in different markets. The new products will line-up in bitop’s established Ectoin® eye product portfolio which consists of eye drops in ampoules or multi-dose units for dry or allergic eyes. Ectoin® containing products are suitable for very sensitive patients and children and do not contain preservatives, where applicable.
Contact our business development team to get to know more about the products and to discuss your license opportunities for our ophthalmology range: firstname.lastname@example.org.
bitop strengthens derma-expertise for the extension of its Ectoin® medical skin care range
Witten, 15.09.2017 - bitop has recently dedicated its research capacities to the development of special formulations for the treatment and prevention of different serious skin diseases. Currently, bitop develops products for the treatment of:
- Hemorrhoids disorders
- Vaginal dryness
Each of these highly specialized products will have a unique Extremolyte-containing formulation with beneficial supportive ingredients. They extend the existing skin care range with Ectoin® for the treatment and prevention of inflammatory skin diseases.
Contact our business development team to get to know more about the products and to discuss your license opportunities for our medical skin care range: email@example.com.
Biohorma launches Ectoin® Ear Spray in the Netherlands
Witten, 18.08.2017 - bitop is proud to announce that its new Ectoin®-containing Ear Spray has recently been launched by the successful Dutch partner Biohorma. Biohorma placed its product “Oorspray Oorsmeer” under the well-known “A. Vogel” brand.
The product is designed to treat symptoms of non-infectious inflammations in the outer ear, for prevention of otitis externa and earwax plugs, and for eased clearing of the outer ear canal.
Dr. Uwe Sonnemann, ENT specialist from Hamburg (Germany) explains why he sees a huge market potential for the product:
“Ear itching severely impairs daily life of numerous people worldwide. Reasons for ear itching are diverse and treatment is often challenging since products that contain pharmaceutical drugs have well-known side effects while natural ear sprays are often not effective enough. bitop has developed an ear spray that fills this gap in the market. Their product “Ectoin® Ear Spray” proved its efficacy in reducing ear itching and other symptoms of inflammatory irritations of the outer ear canal on a safe, natural and very effective way. I feel very confident that the product will successfully establish itself on the OTC market within a short time.”
If you would like to be part of the success story of this innovative product, contact our business development team for more information: firstname.lastname@example.org.
Brand-new Ectoin® Lozenges formulation expands bitop’s successful cough and cold product line
Witten, 16.07.2017 - The unique formulation “Ectoin® Lozenges HC + Salt” contributes to the existing Lozenges range for the treatment and prevention of common cold symptoms, dry mouth and throat, and hoarseness due to voice overuse.
The innovative formulation differentiates itself from the existing Ectoin® Lozenges by the additional ingredient sea salt. Sea salt helps to dissolve thick and compact mucous. Furthermore it increases the saliva production which results in a hydrated epithelia and symptom reduction while suffering from a cold. Strong claims can be used to position the product successfully on the market:
- Reduces inflammations of the mucous membranes in mouth and throat
- Relieves hoarseness, sore throat, or pain on swallowing
- Stabilizes the mucous membranes
- Reduces the danger of bacterial or viral infection in the mouth and throat
- Reduces and prevents irritations of the mucous membranes such as voice fatigue, tickly throat, or dryness caused by voice overuse, allergens or dry air resulting from e.g. heating, cold, air conditioning, or smoke
- Dissolves thick and compact mucus
- Forms a protective shield called “Ectoin® Hydro Complex” on mucous membranes in mouth and throat without leaving a slimy feeling
- Hydrates dry and irritated epithelia and supports their regeneration
- Increases the saliva production
- Effects based on 100% natural ingredients
“Ectoin® Lozenges HC + Salt” lozenges are preservative- and sugar-free – like all bitop formulations. They combine the positive effects of natural sea salt and Ectoin®, a cell-protective molecule with inflammation-reducing and membrane-stabilizing properties. The new Lozenges have a pleasant honey-lemon flavor with a light salty note.
Contact our business development team to discuss your license opportunities for our cough & cold range: email@example.com
Our cosmetic active ingredient Glycoin® natural won the 'Ringier Technology Innovation Award'!
Glycoin® natural was honored in the ‘effective ingredients: anti-aging’ category at the Ringier Technology Innovation Awards 2017 sponsored by happi China magazine. Winners were announced at the awards ceremony on June 22, 2017 in Shanghai, China.
We are proud to show you our award certificate.
EUBOS® extends HAUT RUHE product line with bitop’s Ectoin® based dermatitis formulations.
Witten, 23.05.2017 – Bitop is very proud to announce our new partnership with Dr. Hobein GmbH, one of the German market leader in medical skin care.
Dr. Hobein launched two of bitop's Ectoin® Dermatitis formulations within the “EUBOS® HAUT RUHE” line, a well-known brand specially dedicated for the treatment of children with dry skin and eczema.
With “EUBOS® HAUT RUHE EctoAkut® – 3,5 % Ectoin” and “EUBOS® HAUT RUHE EctoAkut® forte – 7 % Ectoin” Dr. Hobein expands the HAUT RUHE line wth OTC medical devices, perfectly suited for treatment of flare-free intervals as well as for treatment of acute stages of dermatitis.
Both products are now available in pharmacies throughout Germany and Austria.
Construction of a brand-new company headquarter
Since its foundation in 1993, bitop’s office and production area has been located in Witten, Germany. Now, together with our partner Johann Freundlieb GmbH & Co. KG, bitop is constructing a brand-new office building and production facility located in the “PHOENIX West” area - an innovative technology and service location in Dortmund. With a 2000 m² production hall and 1550 m² of office and laboratory space, bitop will be able to significantly expand its production capacity for Ectoin® and other extremolytes. The symbolic “ground-breaking” took place in December 2016 and construction is moving forward. bitop plans to move in its new facilities in Spring 2018.
Laboratoires URGO launches Ectoin®-containing lozenges
As bitop’s first partner for Ectoin®-containing lozenges, we are proud to announce that Laboratoires URGO launched Ectoin®-containing lozenges in France, Belgium and Poland in the fourth quarter of 2016. The Arabic gum based lozenges are positioned under the HUMER brand of Laboratoires URGO (HUMER MAL DE GORGE AIGU PHARYNGITE) in France and Belgium and are perfectly suited to reduce inflammations and to prevent irritations of the mucous membranes in mouth and throat. Due to the membrane-stabilizing effects of Ectoin®, the lozenges also reduce the danger of a bacterial or viral infection in the mouth and throat.
In Poland, the Ectoin® Lozenges are available under the brand name “Ostry Ból Gardła - Laboratoria Polfa Łódź”.
Extension of partnership with company SOLINEA in Poland
In 2016, the company SOLINEA successfully introduced two Ectoin® containing medical devices into the Polish market. bitop’s allergy eye drops and inhalation solution are sold under the brand names “ALECTOIN” and “ECTODOSE”. We are proud to announce that SOLINEA has now decided to extend their portfolio with further Ectoin® containing products that will be launched during the next few months.
Turkish company ILKO launches three Ectoin® containing medical devices under the trademark “Wellcare”
Just recently, ILKO launched bitop’s allergy nasal spray, allergy eye drops and mouth and throat spray under the brand names “Ocnarin Nasal Spray”, “Ocnarin Eye Drops” and “Reliflu Mouth and Throat Spray” in Turkey. By adding these products, ILKO extensively broadened its OTC portfolio in the categories Allergy and Cough and Cold.
Mundipharma launches Ectoin® products at the Duphat 2017.
Dubai, 7th – 9th March 2017
At the DUPHAT, the Dubai International Pharmaceuticals and Technologies Conference and Exhibition (DUPHAT), one of the most important annual pharmaceutical events in the Region, Mundipharma launched the first four Ectoin® based products in the Betadine product range. The products will now be entering the market in 12 countries. Subsequently additional countries and products will follow.
Our cosmetic active ingredient Glycoin® natural won the “PCHi Fountain Award 2017”!
Meet us at
SEPAWA CONGRESS in Berlin,
18-20 October 2017
Meet us in Berlin at the SEPAWA CONGRESS at Stand E722.
CPhI in Frankfurt,
24-26 October 2017
Meet us in Frankfurt at the CPhI Worldwide for pharmaceutical ingredients at Stand 90B01.
in-cosmetics asia in Bangkok,
31 October - 2 November 2017
Meet us in Bangkok at the in-cosmetics asia at DKSH Booth D10.
Making Cosmetics & Formula Cosmetics in Milan,
28-29 November 2017
Meet us in Milan at Making Cosmetics & Formula Cosmetics at URAI Spa Stand 349. Join our presentation "Global anti-pollution, skin protection and repair with clinically proven efficacy: Ectoin®" on 28 November - 15:00-15:20.
in-cosmetics north america in NYC,
11-12 October 2017
Meet us in New York City for the second edition of the in-cosmetics in North America at Stand E56.
in-cosmetics Korea in Seoul,
20-22 June 2017
Meet us in Seoul for the third edition of the in-cosmetics in Korea.
3rd “Future of Formulations in Cosmetics” Conference in Barcelona,
17-18 May 2017
Attend our speech, held by Eva Galik (Senior Business development) with the topic “Anti-pollution in skin care: fad or real need”?
Vitafoods Europe 2017 in Geneva,
Get informed about our innovative extremolytes, latest product developments and our whole product range. We are looking forward to discuss about licensing opportunities with you or to simply refresh our contacts. You will find us at booth number Q127 throughout the event.
in-cosmetics global 2017 in London,
bitop exhibits at the leading event for personal care ingredients and will present latest study data for Ectoin®. Visit us at stand SS72.